Publications by authors named "Frederic Bigot"

Claim this Profile
P
Preventive Behaviors of French Cancer Patients and How They Changed During the COVID-19 Outbreak (PAPESCO-19 Study).
Pauline Petit, Myriam Blanchin, Frederic Bigot, Hakim Mahammedi, Mario Campone

Int J Public Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.
Séverine Guiu, Judith Balmaña, Pablo Lemercier, Philippe Follana, Anthony Gonçalves, Frédéric Bigot

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy.
Natasha B Leighl, Luis Paz-Ares, Delvys Rodriguez Abreu, Rina Hui, Sofia Baka, Frédéric Bigot

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Sample Preparation for Human Chemical Exposomics: Insights from Large-Scale Applications.
Jade Chaker, Eva Gorrochategui Matas, Cécile Chevrier, Mario Campone, Jean-Sébastien Frenel, Frédéric Bigot

Environ Sci Technol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.
Paul Boré, Margaux Geier, Loïc Campion, Jean-Luc Raoul, Ludovic Doucet, Frédéric Bigot

Oncol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.
Edith Borcoman, Bastien Cabarrou, Miguel Francisco, Frédéric Bigot, François Ghiringhelli

Nat Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, Frédéric Bigot

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study.
Alwin Krämer, Tilmann Bochtler, Chantal Pauli, Kai-Keen Shiu, Natalie Cook, Frédéric Bigot

Lancet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
Ke Zhou, Marie Robert, Valérie Seegers, Audrey Blanc-Lapierre, Stéphane Savouroux, Frédéric Bigot

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).
Olivier Molinier, Camille Guguen, Marie Marcq, Anne-Laure Chene, Philippe Masson, Frédéric Bigot

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19).
Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers.
François Bocquet, Judith Raimbourg, Frédéric Bigot, Victor Simmet, Mario Campone

Int J Environ Res Public Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19).
Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19).
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Frédéric Bigot

Clin Med Insights Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study.
Ke Zhou, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Frédéric Bigot

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients.
Mathilde Colombié, Pascal Jézéquel, Mathieu Rubeaux, Jean-Sébastien Frenel, Frédéric Bigot

BMC Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology].
Amandine Billaud, Louise-Marie Chevalier, Mario Campone, Alain Morel, Frédéric Bigot

Bull Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, Adélaïde Renoult, Frédéric Bigot

Ann Pathol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Leptomeningeal Responses with Brigatinib in Two Heavily Pretreated ALK-Rearranged Non-Small Cell Lung Cancer Patients.
Arthur Geraud, Laura Mezquita, Frederic Bigot, Caroline Caramella, David Planchard

J Thorac Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials.
Jean-Marie Michot, Lina Benajiba, Laura Faivre, Capucine Baldini, Lelia Haddag, Frederic Bigot

Invest New Drugs· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
Frédéric Bigot, Eduardo Castanon, Capucine Baldini, Antoine Hollebecque, Alberto Carmona

Eur J Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old.
Frederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, Audrey Thomas-Schoemann, Camille Tlemsani

Invest New Drugs· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
Frédéric Bigot, Clément Bonnet, Christophe Massard

Bull Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for de Quervain's disease in a French working population.
Audrey Petit Le Manac'h, Yves Roquelaure, Catherine Ha, Julie Bodin, Geraldine Meyer, Frederic Bigot

Scand J Work Environ Health· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D insufficiency and acute care in geriatric inpatients.
Aurélien Sutra Del Galy, Maxime Bertrand, Frédéric Bigot, Paul Abraham, Rebecca Thomlinson

J Am Geriatr Soc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis